News & Updates
The latest news and updates from companies in the WLTH portfolio.
China poses biggest long-term competitive threat to SpaceX - Morgan Stanley By Investing.com
Investing.com-- Morgan Stanley said China's rapidly advancing reusable rocket program is emerging as the biggest long-term competitive threat to SpaceX (NASDAQ:SPCX), after the country successfully recovered an orbital-class rocket booster for the first time. The Wall Street brokerage said China's successful recovery of the Long March 10B booster marked a major step toward routine rocket reuse, although it cautioned that Beijing still needs to demonstrate repeated launches and reflights before achieving an operational reusable launch system. Get premium analyst insights, AI-powered research with InvestingPro subscription The brokerage said the China Aerospace Science and Technology Corp. (CASC) became only the third entity after SpaceX and Blue Origin to recover an orbital-class booster, underscoring the country's accelerating ambitions in commercial space. Morgan Stanley analysts said China's deep space ecosystem, spanning state-backed launch programs and private companies such as LandSpace, Galactic Energy and Space Pioneer, makes it the most significant competitive challenge to SpaceX's launch business over the long run. The note highlighted that China carried out 90 orbital launches in 2025, compared with SpaceX's 165 Falcon 9 launches, making it the world's second-largest launch market by activity. U.S. Space Force officials had estimated earlier this year that China was still three to five years away from mastering rocket reusability, although the Long March 10B demonstration could shorten that timeline, Morgan Stanley said. The brokerage also pointed to China's broader space ambitions, including the planned Guowang and Qianfan low-Earth orbit satellite constellations, which together target about 28,000 satellites, as well as a proposed filing for more than 190,000 non-geostationary satellites. Morgan Stanley said China is also investing heavily in space-based computing, citing the launch of the first satellites in the planned 2,800-satellite "Star Compute" orbital supercomputer network. Despite the rising competition, Morgan Stanley maintained its "overweight" rating on SpaceX with a $300 price target, saying the company remains the global leader in launch cadence, reusable rocket technology and satellite connectivity, while warning investors not to underestimate China's progress in narrowing the gap.
Cathie Wood's ARK sees major moves in Coinbase and SpaceX stocks By Investing.com
Cathie Wood's ARK ETF published their daily trades for Friday, July 10th, 2026, revealing significant activity in the tech and biotech sectors. Leading the day's trades, ARK made a substantial purchase of 116,971 shares of Space Exploration Technologies Corp (SPCX), with a total dollar value of $17,798,307. This marks a continuation of ARK's interest in the aerospace giant, following a consistent buying pattern over the past week. In another major move, ARK acquired 87,409 shares of Coinbase Global Inc (NASDAQ:COIN) across its ARKK, ARKW, and ARKF ETFs, amounting to $13,849,081. This purchase indicates ARK's ongoing confidence in the cryptocurrency exchange platform, as it follows recent acquisitions earlier in the week. On the selling side, ARK offloaded 19,540 shares of Advanced Micro Devices Inc (NASDAQ:AMD) through its ARKK, ARKQ, and ARKX ETFs, totaling $10,682,908. This sale continues a trend of reducing its position in AMD, with significant shares sold throughout the week. ARK also sold 158,592 shares of 10X Genomics Inc (NASDAQ:TXG) from its ARKK ETF, totaling $6,835,315, and 45,625 shares of Roku Inc (NASDAQ:ROKU), amounting to $6,399,362. These sales suggest a shift in ARK's focus within the genomics and streaming sectors. In the biotech space, ARK added 293,106 shares of Prime Medicine, Inc (NASDAQ:PRME) through its ARKG ETF, with a total investment of $1,239,838, continuing its recent accumulation of the stock. Additionally, ARK purchased 54,804 shares of Generate Biomedicines Inc (GENB) for $861,518, and 28,276 shares of Tempus AI Inc (TEM) for $1,738,974, reflecting its interest in innovative biotech companies. Other notable trades include the sale of 11,092 shares of Deere & Co (NYSE:DE) for $6,576,446 and the acquisition of 137,071 shares of X-Energy Inc (XE) for $2,275,378, highlighting ARK's diverse investment strategy across various sectors. These trades underscore Cathie Wood's ARK Invest's strategic adjustments within its portfolios, reflecting both confidence in emerging technologies and a reevaluation of existing positions. Investors will be closely watching ARK's next moves as it navigates the evolving market landscape. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Cathie Wood's ARK sells BioNTech and buys SpaceX stock By Investing.com
Cathie Wood's ARK ETF published their daily trades for Wednesday, July 8th, 2026, revealing significant activity in several key stocks. The most notable transaction involved the sale of 78,211 shares of BioNTech SE (NASDAQ:BNTX) through its ARKG ETF, amounting to a substantial $7,374,515. This sale is part of a broader trend, as ARK had also sold 44,330 shares of BioNTech the previous day. On the buying side, ARK made a significant purchase of 181,847 shares of Space Exploration Technologies Corp (SPCX) across multiple ETFs, including ARKK, ARKQ, ARKW, and ARKX, totaling $27,180,671. This marks a continued interest in SpaceX, following a purchase of 44,196 shares just a day earlier. Another noteworthy transaction was the sale of 29,974 shares of Roku Inc (NASDAQ:ROKU) through the ARKW ETF, valued at $4,232,628. This follows a pattern of consistent selling of Roku shares over recent days. Additionally, ARK sold 8,010 shares of Advanced Micro Devices Inc (NASDAQ:AMD) across its ARKK and ARKX ETFs, for a total of $4,134,041. This continues a trend from the previous day when 8,667 shares were sold. Among the smaller trades, ARK sold 11,990 shares of Twist Bioscience Corp (NASDAQ:TWST) through its ARKK ETF, worth $1,091,449, and bought 14,637 shares of Eli Lilly and Co (NYSE:LLY) through its ARKG ETF for $18,084,891. In the biotech sector, ARK continued to adjust its holdings with the sale of 35,859 shares of CareDx Inc (NASDAQ:CDNA) for $1,015,168 and the purchase of 61,750 shares of Generate Biomedicines Inc (GENB) for $1,001,584. Overall, Cathie Wood's ARK ETFs showed a strategic mix of buying and selling, with a continued focus on high-growth sectors such as biotechnology and space exploration. Investors will be closely watching these moves for insights into ARK's investment strategy. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Cathie Wood's ARK sells AMD stock, buys SpaceX and X-Energy By Investing.com
Cathie Wood's ARK ETF published their daily trades for Tuesday, July 7th, 2026, shedding light on significant moves across its portfolio. The most notable transaction was the purchase of 607,567 shares of X-Energy Inc (NASDAQ:XE) through its ARKK ETF, ARKQ ETF, and ARKX ETF, totaling $11,130,627. This continues a trend from previous days, showing ARK's growing interest in X-Energy. In a substantial sell, ARK offloaded 8,667 shares of Advanced Micro Devices Inc (NASDAQ:AMD) through its ARKK ETF, amounting to $4,784,617. This sale follows a pattern, as ARK sold 15,576 shares of AMD the previous day, indicating a potential shift in strategy regarding this stock. ARK also made a significant purchase of 44,196 shares of Space Exploration Technologies Corp (SPCX) through its ARKK ETF, with a total value of $7,089,922. This marks a considerable addition to their holdings, emphasizing ARK's bullish stance on SpaceX. Another notable buy was 6,354 shares of Eli Lilly and Co (NYSE:LLY) via the ARKG ETF, valued at $7,625,181, highlighting ARK's interest in the pharmaceutical sector. On the selling front, ARK divested 44,330 shares of BioNTech SE (NASDAQ:BNTX) from its ARKG ETF, totaling $4,163,916. This follows a broader trend of reducing positions in biotech firms. ARK's ARKG ETF also saw the sale of 72,323 shares of Adaptive Biotechnologies Corp (NASDAQ:ADPT), valued at $1,554,944, and 39,151 shares of CareDx Inc (NASDAQ:CDNA), worth $1,137,728, further reflecting a strategic shift in the biotech space. Meanwhile, ARK increased its stake in Compass Pathways PLC (NASDAQ:CMPS) by acquiring 191,070 shares through the ARKG ETF, amounting to $2,453,338, suggesting confidence in the potential of mental health therapeutics. Additionally, ARK continued to invest in Generate Biomedicines Inc (GENB) with the purchase of 44,170 shares through the ARKG ETF, valued at $747,356, following previous buys in recent days. Finally, ARK sold 40,787 shares of Illumina Inc (NASDAQ:ILMN) across its ARKK and ARKG ETFs, and 20,992 shares of Natera Inc (NASDAQ:NTRA), totaling $5,957,529, showing a consistent pattern of reducing exposure to these genomics companies. These trades illustrate ARK's dynamic investment strategy, balancing between high-conviction buys and strategic sales to optimize its portfolio in the ever-evolving market landscape. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Wall Street warms to SpaceX ahead of Nasdaq 100 inclusion By Reuters
By Purvi Agarwal and Rashika Singh July 7 (Reuters) - SpaceX's addition to the Nasdaq 100 on Tuesday is expected to unleash billions in passive buying, as brokerages kick off coverage of the $2 trillion-plus rocket and satellite company with broadly bullish views. The company joins the index just 15 days after its stock market debut on June 12 - among the fastest inclusions ever - thanks to the Nasdaq's revised rules for newly listed companies looking to enter widely tracked benchmarks. Its debut in the tech-heavy index is set to create another source of demand for its shares as index funds and exchange-traded funds (ETFs) tied to the Nasdaq 100 will need to buy shares to match the benchmark's new composition. Active managers who track the index closely may also adjust their positions. Many retail investors prefer investing in funds to diversify their holdings. Over $587 billion is benchmarked in funds tracking the Nasdaq 100, including Invesco's QQQ and QQQM, which will now have to make room for SpaceX. J.P. Morgan estimated last month that SpaceX's addition to the index could draw $4.3 billion in passive inflows. QUIET PERIOD ENDS Investors are awaiting a wave of reports from Wall Street brokerages making their first attempt to value SpaceX as a publicly traded company, applying traditional valuation metrics to a business that's largely been assessed by investors' belief in Musk's long-term bets. The industry-mandated quiet period ends for analysts at banks that underwrote the blockbuster IPO - led by Goldman Sachs, Morgan Stanley, BofA Securities, Citigroup and J.P. Morgan. Both Morgan Stanley and Goldman Sachs started coverage on the stock on Tuesday with their top ratings, with Morgan Stanley dubbing the company "AI's final frontier." "We see the company as well-positioned to scale its differentiated advantages across space, connectivity, and AI," Goldman analysts said, betting each market has the potential to become a multi-trillion-dollar opportunity over a five-year-plus horizon. Brokerages RBC, Bernstein, and Stifel also initiated coverage with their top ratings, betting on the success of Starship, SpaceX's next-generation rocket that is designed to be fully reusable. "The Starship is the flywheel that powers SpaceX's ambitions," RBC analysts said. Earlier this month, Oppenheimer became the first to initiate coverage with an "outperform" rating. INVESTORS BET ON AI CAPABILITIES Investors are betting SpaceX can evolve into a hyperscale AI infrastructure provider in the near term, using cash generated to fund the development of Grok as it takes on OpenAI's GPT models and Anthropic's Claude. They also see significant room for Starlink to expand its dominance in satellite communications, while much of the company's longer-term ambitions depend on the successful development of its next-generation Starship rocket. However, not everyone is bullish on SpaceX. Morningstar analysts pegged the company's valuation at about $780 billion, citing uncertainty around its AI business, including xAI and social media platform X. With a market capitalization of $2.1 trillion, SpaceX is the sixth-largest U.S. company, and CEO Elon Musk the world's first trillionaire. FTSE Russell added the stock to its U.S. indexes last month, with funds such as iShares Russell 1000 ETF already giving investors a piece of the biggest IPO in U.S. history. However, S&P Global declined to create a similar fast-track process for the benchmark S&P 500 in June, and it is expected to take at least a year before SpaceX joins the world's most widely tracked index. SpaceX shares have gained more than 6% since their debut in their short ride marked by post-IPO volatility.
Anthropic plans to buy 1.4-GW Australian data centre capacity, AFR reports By Investing.com
Investing.com-- Artificial intelligence startup Anthropic is seeking to secure at least 1.4 gigawatts of Australian data centre capacity in a project that could cost as much as $15 billion, the Australian Financial Review reported on Sunday, citing confidential tender documents. The AFR said Anthropic is aiming to begin using at least 1 GW of capacity by the end of 2027 after opening its Australian office earlier this year. Get real-time updates on market-moving news with InvestingPro According to the report, Anthropic's preferred approach is to partner with a developer capable of building a large-scale 1.4 GW-plus data centre campus, while remaining open to jointly developing a suitable site if one is not yet available. The tender was sent to major Australian data centre operators including CDC Data Centres, AirTrunk, Nextdc (ASX:NXT), Iren and Stack, with initial proposals submitted in March and shortlisted bidders meeting company executives in Canberra in April, the AFR said. Anthropic is expected to make a final decision in at least six weeks and could split the project among four or five providers instead of awarding it to a single developer, the AFR reported.
Analysis-A new, inexpensive Chinese AI model is catching up with Anthropic, OpenAI on their home turf By Reuters
By Laurie Chen and Aditya Soni BEIJING/BENGALURU, July 2 (Reuters) - Since DeepSeek shocked markets early last year with its cheap but powerful AI model, global consumers have been faced with a choice: Chinese offerings with lower prices and less capability or OpenAI or Anthropic, which have poured billions into development. A model called GLM-5.2, launched last month by Beijing-based startup Z.ai, may finally be closing that gap in terms of Western interest. GLM-5.2 has Silicon Valley buzzing with its coding and agent capabilities, or the ability to execute complex tasks with minimal prompting, that almost rival leading U.S. offerings at a fraction of the cost, in what some experts are calling a "mini DeepSeek moment." It has quickly climbed the usage charts on third-party AI developer platforms like OpenRouter, where it now ranks above Anthropic's models, while executives from cloud data platform Snowflake's CEO Sridhar Ramaswamy to venture capitalist Marc Andreessen have lauded its abilities. "We now have a Chinese open-weight model that is as good as the currently available models from OpenAI and Anthropic," said David Sacks, U.S. President Donald Trump's former AI czar, last week before Washington lifted curbs on Anthropic's Fable and Mythos models on Tuesday. Those capabilities have put Z.ai's GLM-5.2 model at the heart of a growing debate about whether China is finally catching up to the U.S. in the AI race, as technology executives warn that Washington's unpredictable regulation of the industry risks hampering its lead in the frontier technology. "It is just a tick below Opus 4.8 (from Anthropic) and right up there with GPT 5.5 (from OpenAI)," Sacks said of GLM-5.2 on the All-In podcast, adding that "we cannot afford to do things that slow our companies down." The Anthropic curbs and the delayed public rollout of OpenAI's latest GPT-5.6 model have fueled global demand for the Chinese model, some experts said. "The international developer community is increasingly aware that relying solely on proprietary, U.S.-based API models carries significant risk," said Brian Tse, founder and CEO of Concordia AI, a Beijing-based consultancy focused on AI safety. GLM-5.2's positive global reception also suggests increased interest in cheaper open-source development because businesses are getting stung by the rising and often unpredictable costs of using AI to complete tasks, as closed-source agentic AI tools consume more tokens, the units used to measure AI usage. Z.ai, also known as Zhipu AI, declined to comment. Anthropic and OpenAI did not immediately respond to requests for comment. GLM-5.2 currently holds fifth place on Artificial Analysis' large language model (LLM) intelligence leaderboard, which ranks performance across a range of benchmarks designed to measure overall capability, including reasoning and coding skills. And it is in the second spot on Code Arena's front-end coding rankings, measuring how well models generate websites and front-end applications, while operating at roughly a sixth of the cost of closed U.S. frontier models like Claude and the GPT series. Z.ai has not disclosed how much it spent to develop GLM-5.2. In a reply to Elon Musk on X last month, Z.ai founder Tang Jie said that the Chinese startup could produce a model on par with Anthropic's Fable before the first quarter of next year. "The shift GLM-5.2 brings is that the open-source model has become a plug-and-play, out-of-the-box product," said Tiezhen Wang, former APAC lead at Hugging Face, a startup that serves as a hub for developers tinkering with open-source models. "You just deploy the model and without doing any complex fine-tuning systems, it is in a highly usable, ready-to-use state. This drastically lowers the barrier to entry for open-source adoption." CONVINCING AMERICAN BUSINESSES One major hurdle to GLM-5.2's large-scale adoption remains data security concerns that have limited use of Chinese models by U.S. enterprises, particularly in regulated industries like banking and cybersecurity. The migration and upgrading of enterprise AI systems typically takes several months, Wang said. "I have seen some discussion among European companies about whether it could be used in enterprise settings," said Wei Sun, principal AI analyst at Counterpoint Research. "In the EU and U.S., some clients, partners and regulated industries may simply be unwilling to accept Chinese models in their AI stack, regardless of technical performance or price." A report earlier this year by non-profit RAND, based on website traffic data across 135 countries, found that Chinese LLMs' global market share jumped to 13% from 3% in the two months after DeepSeek launched its R1 model in January last year. The release sparked a global tech selloff because it contrasted DeepSeek's low cost with massive AI infrastructure spending elsewhere. China's LLM usage gains were most pronounced in developing countries and those with close political and economic ties to Beijing. Some experts said concerns about the safety of Chinese AI models were overblown, arguing that running them on U.S. cloud providers or on a company's own servers ensured data security. While major corporations are slow to migrate, tech startups and small- and medium-sized enterprises are moving much faster. "Developers tend to care less about where a model comes from than whether it works, how much it costs and whether they can deploy or access it reliably," said Poe Zhao, China tech analyst and founder of the Hello China Tech newsletter. "The likely pattern is partial routing, not overnight replacement of OpenAI or Anthropic. So yes, it is a mini DeepSeek moment but in a narrower, developer-centric sense."
FAA said to bar employees from buying SpaceX shares By Investing.com
Investing.com -- Federal Aviation Administration workers cannot purchase or own shares in SpaceX following the company's public debut earlier this month, Politico reported Tuesday citing an internal agency document. The restriction stems from FAA's role in licensing SpaceX's commercial spaceflight operations, including launches and reentries, and requiring the company to conduct investigations into rocket incidents. Access breaking news faster with institutional-grade feeds on InvestingPro -- now 50% off. SpaceX started trading on the Nasdaq on June 12 at $150 per share. The stock was trading at approximately $170 per share on Tuesday afternoon. The FAA's ethics office reportedly received numerous inquiries about whether employees could buy shares in the company. The agency's supplemental ethics standards classify SpaceX as a prohibited investment, the report said. The ban extends to employees' spouses and minor children. A federal regulation enforces the FAA mandate, generally preventing agency staff from owning stock in airline companies, aircraft manufacturers, or their parts suppliers, with some exceptions. The FAA updated its prohibited investments list this month to include SpaceX and three other commercial space firms: Blue Origin, Rocket Lab, and Virgin Galactic. Blue Origin remains privately held. The list also features major aircraft manufacturers like Boeing and the country's primary airlines. The FAA stated the list is not comprehensive. The agency reportedly sent an ethics alert to staff on Monday referencing the SpaceX stock restriction and advising workers to review the revised list. The alert did not address any exemptions for political appointees.
Cathie Wood's ARK sells Alibaba and Roku stock, buys Cerebras Systems By Investing.com
Cathie Wood's ARK ETF published their daily trades for Thursday, June 25, 2026, highlighting a significant shift in its investment strategy. The most notable transaction was the purchase of 111,989 shares of Cerebras Systems Inc (NASDAQ:CBRS), totaling $20,411,115. This move suggests a continued confidence in the company, as ARK has been adding to its position in Cerebras over recent days. On the selling front, ARK divested a substantial 176,004 shares of Alibaba Group Holding Ltd (NYSE:BABA), amounting to $17,565,199. This marks a notable reduction in ARK's exposure to the Chinese e-commerce giant. Similarly, ARK sold 130,666 shares of Roku Inc (NASDAQ:ROKU), with a total value of $17,761,429, continuing a recent trend of reducing its stake in the streaming platform. Among other notable buys, ARK acquired 350,023 shares of Robinhood Markets Inc (NASDAQ:HOOD) worth $3,403,885, and 30,528 shares of Palantir Technologies Inc (NYSE:PLTR) valued at $3,464,928. These purchases indicate a strategic focus on technology and innovative platforms. In the biotech space, ARK added 891,473 shares of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) for $2,879,457, and 49,594 shares of Tempus AI Inc (NASDAQ:TEM) totaling $2,575,912. These acquisitions highlight ARK's ongoing interest in cutting-edge healthcare solutions. Conversely, ARK sold 37,555 shares of Twist Bioscience Corp (NASDAQ:TWST) for $3,430,649 and 25,992 shares of Absci Corp (NASDAQ:ABSI) amounting to $2,618,734, indicating a shift away from these biotech investments. Overall, Cathie Wood's ARK ETFs continue to navigate the market with a focus on innovation and technology, while strategically reducing exposure to certain high-profile stocks. Investors will be watching closely to see how these moves align with broader market trends and ARK's long-term investment strategy. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Cathie Wood's ARK buys Cerebras Systems stock, sells Roku shares By Investing.com
Cathie Wood's ARK ETF published their daily trades for Wednesday, June 24th, 2026, revealing a significant purchase in Cerebras Systems Inc (NASDAQ:CBRS) and a continued reduction in Roku Inc (NASDAQ:ROKU). The most notable transaction today was ARK's acquisition of 99,154 shares of Cerebras Systems Inc, totaling $22,480,194. This investment was spread across its ARKK and ARKW ETFs, marking a strong vote of confidence in the AI hardware company. This purchase follows a similar pattern from the previous day, where ARK added 25,795 shares of Cerebras Systems. In contrast, ARK continued its divestment from Roku Inc, selling 65,246 shares for $8,812,124 across multiple ETFs, including ARKK, ARKW, and ARKF. This move is part of a broader trend, as ARK has been consistently reducing its position in Roku over the past week. Another significant buy was 7,293 shares of Eli Lilly and Co (NYSE:LLY) through the ARKG ETF, with a total value of $8,073,934. This follows a substantial purchase of Eli Lilly shares last week, indicating ARK's ongoing interest in the pharmaceutical giant. ARK also increased its holdings in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) by acquiring 260,020 shares valued at $821,663, and added 21,275 shares of Tempus AI Inc (NASDAQ:TEM) for $1,034,177. On the selling side, ARK offloaded 675,357 shares of Absci Corp (NASDAQ:ABSI) through its ARKG ETF, amounting to $5,004,395. Additionally, ARK sold 29,686 shares of Twist Bioscience Corp (NASDAQ:TWST) for $2,523,310, continuing a sell-off trend seen earlier in the week. The trades also included smaller transactions such as the purchase of 31,998 shares of Alamar Biosciences Inc (NASDAQ:ALMR) for $734,034, and 50,900 shares of Generate Biomedicines Inc (NASDAQ:GENB) for $785,387. Meanwhile, ARK sold 56,358 shares of Strata Critical Medical Inc (NASDAQ:SRTA) for $313,914. These moves reflect ARK's strategic shifts in its portfolio, with a notable focus on AI and biotechnology sectors, while scaling back on certain media and technology holdings. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
The SpaceX Sell-Off May Be More Than a Market Overreaction
The commercial space economy is changing fast. The cost of delivering payloads into orbit is declining rapidly, a powerful tailwind that creates exceptional revenue potential for companies in the aerospace sector. The secular expansion of global satellite networks isn't a future idea anymore. It is an active, physical economy generating real cash flows. Investors are rightly looking at low-Earth orbit as the next major growth frontier, recognizing that orbital infrastructure will power global communications for decades to come. Diluting the Dream: SpaceX Becomes a Conglomerate SpaceX (SPCX) is currently broadcasting severe financial warning signs during this sector-wide boom. The company recently executed the largest public debut on record, raising over $85 billion after underwriters fully exercised their overallotment options. Investors naturally assumed SpaceX would deploy that capital directly toward deep-space launch capabilities or orbital logistics. Instead, SpaceX is using it to mutate into a highly leveraged technology conglomerate. The story of an untouchable aerospace monopoly is starting to crack. SpaceX has made a surprise push into AI infrastructure and is leaning on unsecured debt to fund it. By directing resources toward terrestrial server racks rather than orbital dominance, SpaceX is actively diluting the premium valuation that retail and institutional investors just paid top dollar to acquire. This figurative dilution of the company's aerospace premium was immediately followed by a literal dilution of its shares. Just days after the public offering, SpaceX executed a $60 billion all-stock acquisition of Anysphere, the developer of the AI coding platform Cursor. By using its newly minted public equity as currency to acquire the software startup, management triggered an immediate 3.4% dilution of existing shareholders' equity. Expanding the outstanding share count to fund non-core software operations ahead of impending insider lock-up expirations actively eroded the value that retail investors thought they had just purchased. Salvage Operations: Renting Out Failed AI Infrastructure To understand the shifting fundamentals at SpaceX, you have to look at how capital is currently being allocated on the ground. SpaceX leadership has increasingly diverted resources toward massive, capital-intensive AI infrastructure. Initially, SpaceX built the Colossus 1 supercomputing cluster in Memphis, Tennessee, to train large language models. Internal engineering teams quickly hit a technical wall. Latency bottlenecks severely restricted data transfer speeds between campuses located 10 miles apart, rendering the supercomputer entirely unusable for its intended internal training purposes. Instead of writing down the technical failure, SpaceX pivoted to a landlord model. SpaceX began renting out the Colossus 1 compute capacity to Anthropic for $1.25 billion per month. Now, SpaceX is doubling down on this real estate strategy. SpaceX recently signed a $6.3 billion agreement with Reflection AI to lease graphics processing units at its Colossus 2 data center, generating an additional $150 million in monthly recurring revenue. Finding external tenants to monetize sunk infrastructure costs might look like a savvy salvage operation to a casual observer. Structurally, though, it transforms the aerospace pioneer into an infrastructure middleman. Maintaining massive data centers to support external clients strips focus and cash away from core launch vehicle development. This compute lease also features a mutual 90-day cancellation clause. Relying on highly fragile, easily terminated contracts to justify astronomical capital expenditures leaves SpaceX deeply exposed if the AI spending cycle cools. Unsecured Baggage: The $20B Post-IPO Debt Trap The most glaring red flag for fundamental investors arrived just 10 days after the public offering. Despite boasting a reported $100.8 billion cash balance heavily padded by IPO proceeds, SpaceX immediately tapped the bond market to issue $20 billion in senior unsecured notes. When an executive team raises record equity capital only to immediately issue massive unsecured debt, the broader market takes notice. Issuing debt so quickly after a historic stock debut suggests that core operating cash flows are insufficient to self-fund ongoing capital expenditures. The structure of the debt itself warrants intense scrutiny. Unsecured notes are not backed by physical collateral, such as launch facilities or satellite constellations. They operate entirely on corporate faith and sit on equal footing with SpaceX's other senior debts. By injecting an additional $20 billion in unsecured obligations into the capital stack, SpaceX is actively pushing public shareholders further down the line to get paid in the event of a liquidation or restructuring. Digging into the SEC filings reveals exactly what this capital raise was for. The $20 billion note offering is specifically earmarked to refinance a massive bridge loan from March 2026. SpaceX originally used that bridge loan to pay off xAI's debt after buying the company. The bond market is not funding the next generation of Starship. It is cleaning up the speculative, pre-IPO liabilities of a sister company. Priced for Perfection, Grounded by Financial Reality Equity markets are rapidly repricing these capital allocation risks. SpaceX shares violently re-rated from a post-IPO peak of $225.64, plummeting 31.5% to $154.60. That downward momentum erased roughly $600 billion in market capitalization. Trading at roughly 71X enterprise value to EBITDA requires absolute operational perfection. A sprawling conglomerate structure leaves no room for friction, yet friction is appearing right in the core cash engine. SpaceX relies almost entirely on its Starlink satellite broadband unit for positive free cash flow. While subscriber growth remains steady, the company's aggressive expansion into emerging markets is triggering severe margin compression. Average revenue per user dropped drastically from $99 per month in 2023 to just $66 per month in the first quarter of 2026. Launching and maintaining a low-Earth orbit satellite costs SpaceX the exact same amount regardless of whether the end-user pays high-tier enterprise rates in North America or heavily subsidized rates globally. Failing to stabilize these unit economics while simultaneously funding massive terrestrial data centers threatens to break the balance sheet. With long-term financial modeling projecting that net debt could balloon to $400 billion or more by 2031, the transition from an asset-light innovator to a heavily leveraged, hardware-centric utility is in full swing. Safe Landings: Getting on the Right Ship The retail frenzy surrounding the historic IPO temporarily drained cash from the rest of the aerospace sector. Portfolio managers and individual investors liquidated positions in smaller space companies to chase the headline event. This capital rotation triggered a sharp sell-off across the industry, heavily discounting otherwise sound aerospace businesses. Savvy investors recognize that this sector dilution represents a profound mispricing of risk and creates highly attractive entry points for pure-play operators unburdened by AI bailouts or legacy debt. Rocket Lab (NASDAQ:RKLB) and AST SpaceMobile (NASDAQ:ASTS) offer unencumbered exposure to the secular expansion of the space economy. Both operators maintain clean balance sheets, possess proven orbital delivery systems, and have upcoming catalysts, without carrying an astronomical forward multiple. For those seeking diversified exposure to the broader macro tailwinds of space commercialization without single-stock execution risk, the Procure Space ETF (NASDAQ:UFO) provides a highly strategic vehicle. Investors heavily allocated to SpaceX may want to strictly evaluate their risk parameters as the massive August lock-up expirations approach. Cautious investors might prefer to wait for the conglomerate discount to fully materialize, opting instead to capture orbital growth through heavily discounted satellite and launch infrastructure operators that were temporarily left behind in the liquidity drain.
SpaceX Is Down 22% From Its High, but Investors Aren't Losing Faith
What a difference a week makes. When SpaceX completed the largest IPO in history last week, it briefly tipped the company's valuation above $2 trillion, helping make Elon Musk the world's first trillionaire in the process. However, since then, shares have fallen sharply from their dizzying highs, at one point dropping roughly 18%. The initial frenzy around the IPO was easy to understand. SpaceX is arguably the most important private space company ever, operating the world's largest satellite network through Starlink while becoming firmly embedded in government and defense infrastructure. After a highly anticipated landmark IPO, it's not uncommon for the market to take a step back and reassess how much of the future growth potential should be reflected in the share price. It's important to note that SpaceX is not a pure space company anymore. Investors are essentially buying Elon Musk's broader vision around AI, data centers, chip manufacturing and next-gen computing infrastructure. This week CNBC reported that AI startup Reflection signed a multibillion-dollar agreement to access computing capacity at SpaceX's Colossus 2 data center, adding to a growing list of AI-related partnerships around the company. While Elon's bold ambitions create huge upside potential, they are also shrouded in uncertainty, which means the company's future trajectory is incredibly difficult to value. I don't think the recent drop in stock price represents waning investor interest in SpaceX. I remember how Tesla spent years being traded based on lofty future prospects, not necessarily on its real-time activity. At the time, most investors were in one of two camps, believing the stock was either wildly overvalued or dramatically misunderstood. In 2026, SpaceX is in a similar boat. The SpaceX IPO itself created an unusual situation where demand dramatically outpaced supply. As additional shares eventually enter the market through lockup expirations and index inclusion processes, the stock could experience periods of heightened volatility, irrespective of how the underlying business is performing. Stanislav Galandzovskyi, who works directly with major fintech firms noted: "SpaceX's drop isn't about losing faith in the vision, but it's the market realizing you can't acquire a trillion-dollar valuation the way you acquire customers. The IPO was a discount offer everyone rushed, now investors are asking: where's the retention loop, the owned distribution, the proof that this empire scales beyond hype?" The main thing to take away is that the recent drop in stock price doesn't seem to be a judgment on SpaceX's future. It looks more like the market is trying to figure out how much of SpaceXs future is already reflected in the stock price. Right now the market is trying to put a price on a SpaceX future that spans innovative AI deployments, breakthrough defense technology and maybe even whole new verticals that don't exist yet. While the excitement is palpable, this sort of possibility and uncertainty ensures that the only short-term certainty for the share price is it's volatility.